Table 2. Correlation between the expression of miR-182, ST6GALNAC5, and clinicopathological factors of patients with prostate cancer (n=25).
| Variable | miR-182 expression | P value | ST6GALNAC5 | P value | ||
|---|---|---|---|---|---|---|
| Low (n=13) | High (n=12) | Low (n=14) | High (n=11) | |||
| Age (years) | ||||||
| <60 | 5 | 5 | 0.870 | 8 | 6 | 0.897 |
| ≥60 | 8 | 7 | 6 | 5 | ||
| Lymph node metastasis | ||||||
| Not detected | 10 | 4 | 0.028* | 5 | 8 | 0.066 |
| Detected | 3 | 8 | 9 | 3 | ||
| Tumor Size (cm) | ||||||
| ≤4.0 | 11 | 5 | 0.025* | 3 | 7 | 0.032* |
| >4.0 | 2 | 7 | 11 | 4 | ||
| Clinical Stage | ||||||
| I-II | 8 | 3 | 0.066 | 5 | 6 | 0.346 |
| III-IV | 5 | 9 | 9 | 5 | ||
| Distant metastasis | ||||||
| Not detected | 9 | 3 | 0.027* | 4 | 8 | 0.028* |
| Detected | 4 | 9 | 10 | 3 | ||
Low/high cutoff by the sample mean. *P<0.05 was considered statistically significant (Pearson chi-squared test).